Clinical Trials Logo

Obese clinical trials

View clinical trials related to Obese.

Filter by:

NCT ID: NCT04406922 Completed - Healthy Clinical Trials

Circadian Rhythmicity in Cold-induced Thermogenesis

COLDR
Start date: April 23, 2019
Phase: N/A
Study type: Interventional

This study aims to investigate whether maximum cold-induced non-shivering thermogenesis (e.g. thermogenesis as a consequence of BAT activity) differs between morning and evening.

NCT ID: NCT04392882 Completed - Obese Clinical Trials

Effects of Legumes Consumption on Weight Reduction

Start date: March 1, 2011
Phase: N/A
Study type: Interventional

This is a 12-week, randomized nutritional intervention study to determine the effect of legumes consumption on body weight in obese subjects.

NCT ID: NCT04307628 Withdrawn - Healthy Clinical Trials

Response of Gut Microbiota and Cardiometabolic Biomarkers to Consumption of Walnuts

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The researchers will investigate blood and fecal responses in qualified study participants after eating walnuts for 4 weeks compared to not eating walnuts for 4 weeks. The two dietary interventions will be separated by a 4 week washout period. The order of diets will be random; study participants will complete both interventions. Dietary modifications will be part of the study protocol.

NCT ID: NCT04299854 Completed - Obese Clinical Trials

Modality of Induction of Labor in Obese Women at Term (MODOBAT)

MODOBAT
Start date: June 11, 2020
Phase:
Study type: Observational

In normal-weight patients, numerous studies show an equivalence of efficacy between dinoprostone and balloon to induce labor. In obese patients, this efficacy is not known, although inductions of labor are more frequent. MODOBAT aims to describe the ability to obtain a vaginal delivery of two modality of induction of labor (vaginal dinoprostone and single balloon Foley catheter) in obese women at term.

NCT ID: NCT04255264 Recruiting - Obese Clinical Trials

Adipose Inflammation and Diabetes (FAB)

FAB
Start date: August 1, 2019
Phase:
Study type: Observational

The study investigates whether the addition of resolution molecules can inhibit inflammation and insulin resistance in human tissue taken from obese individuals, and whether the results of these studies correlate with patient-specific resolution phenotypes.

NCT ID: NCT04234295 Completed - Healthy Clinical Trials

Investigating the Effect of Obesity on Eosinophil Recruitment in Human Adipose Tissue

Start date: January 29, 2020
Phase: N/A
Study type: Interventional

Researchers are trying to better understand the relationship between inflammation in adipose tissue (AT) and insulin resistance.

NCT ID: NCT04175678 Recruiting - Obese Clinical Trials

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

Start date: February 21, 2020
Phase: N/A
Study type: Interventional

This is a rigorous, controlled clinical trial designed to show that diet, exercise training, and their combination in overweight, inactive men will alter epigenetic programming to create a "healthy" sperm epigenome. Our central hypotheses are: i) overweight and inactive lifestyle results in epimutations in the sperm epigenome relative to the normal epigenetic programming in lean and active men and ii) diet and exercise modulation leads to reversal of these epimutations resulting in both a healthier "phenotype" and "epigenotype" which may persist after stopping the interventions. The study is divided into three parts: 1. We will recruit 20 healthy, active men and 20 obese and inactive Hispanic men between 18 and 40 years to determine the differences in sperm epigenome (DNA methylation, histone modifications and non-coding RNAs) in a cross-sectional study in obese inactive vs. healthy active Hispanic men. Only Hispanic men will be studied because of the high prevalence of obesity and inactivity in Hispanic younger men and to reduce the genetic variability influencing the epigenome. 2. 80 obese and inactive men will be randomized to 4 groups of 20 men: 1) No intervention (control); 2) Low fat, low caloric diet; 3) Supervised, periodized endurance and resistance training without modification of diet; and 4) Both exercise and diet modification to characterize the plasticity of the sperm epigenome in response to 12-week diet and/or exercise training interventions in obese and inactive Hispanic men. Sperm epimutations will be compared before and after intervention within each group and between groups. 3. The sperm epigenome studies in 80 men randomized to no intervention or diet and/or exercise training will be repeated at 12 and 36 weeks after cessation of interventions to Identify the persistent effects of diet and exercise training on the sperm epigenome after stopping the interventions.

NCT ID: NCT04149288 Active, not recruiting - Healthy Clinical Trials

Olive Oil Polyphenols and Cardiovascular Health Biomarkers

Start date: October 6, 2021
Phase: N/A
Study type: Interventional

The purpose of this research is to investigate whether consuming two different kinds of olive oil will change risk factors related to cardiovascular disease, including levels of good and bad cholesterol, levels of inflammation, and levels of gene expression.

NCT ID: NCT04115657 Completed - Obese Clinical Trials

The Effect of Different Starches of Boba Pearls and Sugar Substitutes Used in Milk Tea on Glycaemia, Insulinaemia and Appetite Control (Pearl Study)

Start date: May 2, 2019
Phase: N/A
Study type: Interventional

The first objective is to investigate the effect of boba pearls made from different starches on glycaemia, insulinaemia and appetite control. The second objective is to investigate the effects of various sugar blends of sucrose with sugar substitutes in milk tea on glycaemia, insulinaemia and appetite control.

NCT ID: NCT04105075 Completed - Copd Clinical Trials

COPD in Obese Patients

Start date: September 9, 2018
Phase:
Study type: Observational

The study included 176 patients with COPD. The first group included 88 normal weight patients with COPD: 71 men and 17 women, mean age 62.40 ± 8.83 years. The second group included 88 patients with COPD and obesity: 64 men and 24 women, mean age 62.94 ± 5.96 years. We assessed the frequency of COPD exacerbations in last 12 months, the severity of symptoms such as dyspnea, sputum production, fatigue. Spirometry, six-minute walk test and analysis of body tissue type composition were performed. BODE index was calculated. Levels of leptin, adiponectin, interleukins-4,6,8,10, interferon-γ, c-reactive protein (CRP), tumor necrosis factor receptor 1 (TNF-R1), tumor necrosis factor receptor 2 (TNF-R2), tumor necrosis factor alpha (TNF-α) were measured in blood serum.